Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals and wellness company, today announced its standalone and ...
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $212.73, a high ...